Clinical trial · no report yet · Phase 2/Phase 3
NCT06367972
A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)
- NCT06367972 ↗
- Recruiting
- M.D. Anderson Cancer Center
- Standard
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 13 | |
| YouTube | 2 |
The trial
ClinicalTrials.gov- Official title
- A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)
- Phase
- Phase 2/Phase 3
- Status
- Recruiting
- Conditions
- OligoProgressive Metastatic Disease
- Interventions
- Local Consolidation Therapy; Next-line Systemic Therapy
- Arms
- NLST Arm · Experimental
- LCT Arm · Experimental
- Enrollment
- 400 (estimated)
- Primary outcomes
- Safety and adverse events (AEs)
- Sponsor
- M.D. Anderson Cancer Center
- Start
- Jun 6, 2024
- Primary completion
- Oct 10, 2028 (estimated)
- Results posted
- No
- Registry record
- NCT06367972 · updated Jun 11, 2026